Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
China
· Delayed Price · Currency is CNY 23.01
-0.04 (-0.17%)
Mar 9, 2026, 4:00 PM EDT
SHE:001367 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Market Capitalization | 3,459 | 2,796 | 2,989 | - | - | - | Upgrade
|
| Market Cap Growth | 23.57% | -6.46% | - | - | - | - | Upgrade
|
| Enterprise Value | 2,459 | 1,832 | 2,063 | - | - | - | Upgrade
|
| Last Close Price | 23.01 | 18.30 | 19.69 | - | - | - | Upgrade
|
| PE Ratio | 28.16 | 22.82 | 28.56 | - | - | - | Upgrade
|
| PS Ratio | 6.78 | 5.93 | 7.52 | - | - | - | Upgrade
|
| PB Ratio | 2.42 | 2.08 | 2.39 | - | - | - | Upgrade
|
| P/TBV Ratio | 2.63 | 2.11 | 2.43 | - | - | - | Upgrade
|
| P/FCF Ratio | 1301.72 | 27.31 | 128.99 | - | - | - | Upgrade
|
| P/OCF Ratio | 22.49 | 16.73 | 37.08 | - | - | - | Upgrade
|
| EV/Sales Ratio | 4.82 | 3.89 | 5.19 | - | - | - | Upgrade
|
| EV/EBITDA Ratio | 17.31 | 13.90 | 18.18 | - | - | - | Upgrade
|
| EV/EBIT Ratio | 19.87 | 15.70 | 20.45 | - | - | - | Upgrade
|
| EV/FCF Ratio | 925.29 | 17.89 | 89.04 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0 | 0.00 | 0.00 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.06 | 0.06 | 0.00 | 0.01 | 0.01 | - | Upgrade
|
| Debt / FCF Ratio | 3.23 | 0.08 | 0.01 | 0.01 | 0.02 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.70 | -0.76 | -0.75 | -0.52 | -0.57 | -0.50 | Upgrade
|
| Net Debt / EBITDA Ratio | -7.11 | -7.79 | -8.31 | -2.08 | -1.74 | -1.71 | Upgrade
|
| Net Debt / FCF Ratio | -376.43 | -10.02 | -40.72 | -4.50 | -2.77 | -2.52 | Upgrade
|
| Asset Turnover | 0.34 | 0.33 | 0.42 | 0.81 | 0.93 | 0.80 | Upgrade
|
| Inventory Turnover | 2.17 | 2.05 | 1.57 | 2.15 | 2.47 | 2.25 | Upgrade
|
| Quick Ratio | 9.09 | 9.33 | 12.90 | 3.53 | 2.46 | 2.33 | Upgrade
|
| Current Ratio | 10.31 | 10.31 | 14.95 | 5.35 | 3.51 | 3.46 | Upgrade
|
| Return on Equity (ROE) | 9.05% | 9.45% | 12.18% | 25.91% | 29.36% | 23.04% | Upgrade
|
| Return on Assets (ROA) | 5.21% | 5.16% | 6.62% | 12.59% | 15.61% | 12.49% | Upgrade
|
| Return on Invested Capital (ROIC) | 24.73% | 32.36% | 33.13% | 48.12% | 61.17% | 45.27% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.50% | 8.60% | 8.00% | 21.80% | 28.00% | 24.80% | Upgrade
|
| Earnings Yield | 3.58% | 4.38% | 3.50% | - | - | - | Upgrade
|
| FCF Yield | 0.08% | 3.66% | 0.78% | - | - | - | Upgrade
|
| Dividend Yield | 0.50% | 0.63% | 1.16% | - | - | - | Upgrade
|
| Payout Ratio | 14.81% | 27.74% | - | 0.66% | 17.48% | 85.77% | Upgrade
|
| Buyback Yield / Dilution | -1.21% | -9.35% | -22.74% | 0.02% | - | 0.16% | Upgrade
|
| Total Shareholder Return | -0.71% | -8.72% | -21.58% | 0.02% | - | 0.16% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.